Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

46.47EUR
11:35am EDT
Change (% chg)

€0.34 (+0.73%)
Prev Close
€46.13
Open
€45.91
Day's High
€46.61
Day's Low
€45.88
Volume
1,069,252
Avg. Vol
1,650,222
52-wk High
€71.00
52-wk Low
€38.28

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Overall

Beta: 0.85
Market Cap(Mil.): €25,670.78
Shares Outstanding(Mil.): 556.49
Dividend: 0.80
Yield (%): 1.73

Financials

  FREG.DE Industry Sector
P/E (TTM): 12.61 23.09 37.45
EPS (TTM): 3.66 -- --
ROI: 9.87 8.96 12.16
ROE: 13.65 0.13 16.93

Fresenius says tighter EU rules could trigger antibiotic shortage

FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.

Jun 05 2019

Fresenius says tighter EU rules could trigger antibiotic shortage

* Regulator EMA working on revision of manufacturing guidelines

Jun 05 2019

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

May 17 2019

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN, May 17 German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

May 17 2019

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

May 15 2019

UPDATE 1-Fresenius talking to potential suitors about sale of blood transfusion business - sources

* Fresenius has hired Goldman Sachs for potential sale - sources

May 10 2019

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT, May 10 Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

May 10 2019

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

May 02 2019

Fresenius makes solid start to Q1 after troubled 2018

BERLIN, May 2 Fresenius reported a quarter of solid sales and earnings growth on Thursday helped by its generic infusion drugs and dialysis units and signs of stabilisation at its troubled German hospital business.

May 02 2019

Fresenius may not be ideal owner for some business activities: CEO

DUESSELDORF, Germany German healthcare group Fresenius is happy with its current portfolio but may consider selling some non-core business activities within its units, its chief executive told an association of business journalists on Wednesday evening.

Apr 11 2019

Earnings vs. Estimates